Athersys
ATHX
#11224
Rank
C$1.18 M
Marketcap
C$0.01924
Share price
-33.50%
Change (1 day)
-98.88%
Change (1 year)

Earnings for Athersys (ATHX)

Earnings in 2023 (TTM): -C$56.23 Million

According to Athersys's latest financial reports the company's current earnings are C$0.08 Million. In 2022 the company made an earning of -C$0.11 Billion, an increase over its 2021 earnings that were of -C$0.13 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Athersys from 2007 to 2023

Annual earnings

Year Earnings Change
2023 (TTM) -C$56.23 Million-48.78%
2022 -C$0.11 Billion-11.54%
2021 -C$0.13 Billion11.14%
2020 -C$0.12 Billion72.2%
2019 -C$64.84 Million77.29%
2018 -C$36.58 Million-22.91%
2017 -C$47.45 Million111.89%
2016 -C$22.4 Million-8.52%
2015 -C$24.48 Million-40.81%
2014 -C$41.36 Million18.62%
2013 -C$34.87 Million
2011 -C$19.65 Million19.71%
2010 -C$16.41 Million-26.28%
2009 -C$22.26 Million-18.21%
2008 -C$27.22 Million-8.28%
2007 -C$29.67 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
C$37.35 B-62,855.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
C$9.84 B-16,638.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
C$14.66 B-24,732.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
C$10.20 B-17,245.47%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
C$10.96 B-18,513.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$16.97 B-28,618.75%๐Ÿ‡บ๐Ÿ‡ธ USA
United States Lime & Minerals
USLM
C$0.24 B-512.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Moderna
MRNA
-C$4.35 Billion 7,191.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Arena Pharmaceuticals
ARNA
-C$0.9 Billion 1,401.18%๐Ÿ‡บ๐Ÿ‡ธ USA